Martingale Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
Martingale Asset Management's IRMD Position: Q2 2026 in Review
Martingale Asset Management increased its iRadimed (IRMD) stake by 29% in Q2 2026, buying an estimated $328K and bringing the position to 15,830 shares worth $1.51M. The position accounts for 0.04% of the portfolio, ranked #446.
Martingale Asset Management first reported a position in IRMD in Q3 2020 and has held it in 20 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Martingale Asset Management held 15,830 shares of iRadimed worth $1.51M as of Q2 2026.
- Martingale Asset Management bought 3,600 iRadimed shares in Q2 2026, an estimated $328K.
- iRadimed made up 0.04% of Martingale Asset Management's portfolio in Q2 2026, its #446 holding.
- Martingale Asset Management first reported a position in iRadimed in Q3 2020 and has held it in 20 quarters since.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.